AUA 2021: Relugolix vs Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate Cancer
AUA 2021 Phase 3 HERO Study, gonadotropin-releasing hormone (GnRH) agonists and antagonists, Relugolix vs Leuprolide, safety and efficacy of relugolix in men with advanced prostate cancer.